ROIVRoivant Sciences Ltd.
−2.6% today · +101.4% over a year
1/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 16% of the instruments we score
Trend: among the best of its peers; Quality: among the weakest; priced higher than most peers. No dividend.
Ratios vs sector
Medians of Health care companies in the same region (stocks and REITs).
| Metric | ROIV | Sector median | vs median |
|---|---|---|---|
| P/E | — | 22.4 · n=22 | — |
| P/B | 6.2 | 3.6 · n=39 | 71% above |
| P/S | 3,499.4 | 4.5 · n=34 | 77,920% above |
| EV/EBIT | — | 21.8 · n=22 | — |
| Free-cash-flow yield | −2.9% | 2.2% · n=37 | 231% below |
| Dividend yield | 0.00% | 0.13% · n=100 | 100% below |
| Return on equity | −6.2% | 4.2% · n=50 | 249% below |
| Return on invested capital | −19.6% | 6.5% · n=41 | 402% below |
| Gross margin | — | 70.5% · n=33 | — |
| Net debt / EBITDA | — | 1.39 · n=22 | — |
Value factor: 5 of 100 within the peer group. Full score breakdown →
Sector peers
The largest companies of the same sector and region.
| Instrument | P/E | P/B | EV/EBIT | Free-cash-flow yield | Dividend yield | Smart Score |
|---|---|---|---|---|---|---|
| NOVNNovartis AG | 21.2 | 6.4 | 17.8 | 5.9% | 2.9% | 10/10 |
| NVSNovartis AG | 20.6 | 6.3 | 17.3 | 6.1% | 3.2% | 10/10 |
| AZNAstraZeneca PLC | 26.0 | 5.5 | 21.1 | 4.4% | 1.3% | 6/10 |
| NVONovo Nordisk A/S | 11.3 | 6.0 | 9.9 | 5.1% | 4.7% | 8/10 |
| SNYSanofi | 11.6 | 1.3 | 16.0 | 8.0% | 5.0% | 7/10 |
| SANSanofi SA | 11.6 | 1.3 | 15.9 | 8.0% | 5.6% | 9/10 |
| TEVATeva Pharmaceutical Industries Limited | 65.0 | 5.9 | 36.8 | 2.9% | 0.0% | 6/10 |
| ALCAlcon AG | 35.0 | 1.6 | 27.5 | 5.0% | 0.5% | 5/10 |
| ALCAlcon | 34.9 | 1.6 | 27.5 | 5.1% | 0.5% | 5/10 |
| STESTERIS | 28.1 | 3.1 | 21.1 | 4.1% | 0.8% | 8/10 |
Fiscal-year history
From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.
Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 Jun 2026 · filed 06 Aug 2026
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.